Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 217 to 228 of 228 entries
Sorted by: Best Match Show Resources per page
Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape.

Journal of community genetics

Kalokairinou L, Howard HC, Slokenberga S, Fisher E, Flatscher-Thöni M, Hartlev M, van Hellemondt R, Juškevičius J, Kapelenska-Pregowska J, Kováč P, Lovrečić L, Nys H, de Paor A, Phillips A, Prudil L, Rial-Sebbag E, Romeo Casabona CM, Sándor J, Schuster A, Soini S, Søvig KH, Stoffel D, Titma T, Trokanas T, Borry P.
PMID: 29150824
J Community Genet. 2018 Apr;9(2):117-132. doi: 10.1007/s12687-017-0344-2. Epub 2017 Nov 18.

Despite the increasing availability of direct-to-consumer (DTC) genetic testing, it is currently unclear how such services are regulated in Europe, due to the lack of EU or national legislation specifically addressing this issue. In this article, we provide an...

Cite
Kalokairinou L, Howard HC, Slokenberga S, et al. Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape. J Community Genet. 2017;9(2):117-132doi: 10.1007/s12687-017-0344-2.
Kalokairinou, L., Howard, H. C., Slokenberga, S., Fisher, E., Flatscher-Thöni, M., Hartlev, M., van Hellemondt, R., Juškevičius, J., Kapelenska-Pregowska, J., Kováč, P., Lovrečić, L., Nys, H., de Paor, A., Phillips, A., Prudil, L., Rial-Sebbag, E., Romeo Casabona, C. M., Sándor, J., Schuster, A., Soini, S., Søvig, K. H., Stoffel, D., Titma, T., Trokanas, T., & Borry, P. (2018). Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape. Journal of community genetics, 9(2), 117-132. https://doi.org/10.1007/s12687-017-0344-2
Kalokairinou, L, et al. "Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape." Journal of community genetics vol. 9,2 (2018): 117-132. doi: https://doi.org/10.1007/s12687-017-0344-2
Kalokairinou L, Howard HC, Slokenberga S, Fisher E, Flatscher-Thöni M, Hartlev M, van Hellemondt R, Juškevičius J, Kapelenska-Pregowska J, Kováč P, Lovrečić L, Nys H, de Paor A, Phillips A, Prudil L, Rial-Sebbag E, Romeo Casabona CM, Sándor J, Schuster A, Soini S, Søvig KH, Stoffel D, Titma T, Trokanas T, Borry P. Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape. J Community Genet. 2018 Apr;9(2):117-132. doi: 10.1007/s12687-017-0344-2. Epub 2017 Nov 18. PMID: 29150824; PMCID: PMC5849704.
Copy Download .nbib Format: NLM
Attitudes of cystic fibrosis patients and their parents towards direct-to-consumer genetic testing for carrier status.

Personalized medicine

Janssens S, Kalokairinou L, Chokoshvilli D, Binst C, Mahieu I, Henneman L, De Paepe A, Borry P.
PMID: 29754534
Per Med. 2015 Mar;12(2):99-107. doi: 10.2217/pme.14.75.

BACKGROUND: An increasing number of direct-to-consumer (DTC) genetic testing companies have started offering tests for carrier status of autosomal recessive disorders.MATERIALS & METHODS: A written questionnaire was administered to 47 patients and 65 parents of children with Cystic Fibrosis...

Cite
Janssens S, Kalokairinou L, Chokoshvilli D, et al. Attitudes of cystic fibrosis patients and their parents towards direct-to-consumer genetic testing for carrier status. Per Med. 2015;12(2):99-107doi: 10.2217/pme.14.75.
Janssens, S., Kalokairinou, L., Chokoshvilli, D., Binst, C., Mahieu, I., Henneman, L., De Paepe, A., & Borry, P. (2015). Attitudes of cystic fibrosis patients and their parents towards direct-to-consumer genetic testing for carrier status. Personalized medicine, 12(2), 99-107. https://doi.org/10.2217/pme.14.75
Janssens, Sandra, et al. "Attitudes of cystic fibrosis patients and their parents towards direct-to-consumer genetic testing for carrier status." Personalized medicine vol. 12,2 (2015): 99-107. doi: https://doi.org/10.2217/pme.14.75
Janssens S, Kalokairinou L, Chokoshvilli D, Binst C, Mahieu I, Henneman L, De Paepe A, Borry P. Attitudes of cystic fibrosis patients and their parents towards direct-to-consumer genetic testing for carrier status. Per Med. 2015 Mar;12(2):99-107. doi: 10.2217/pme.14.75. PMID: 29754534.
Copy Download .nbib Format: NLM
Genome-based newborn screening: a conceptual analysis of the best interests of the child standard.

Personalized medicine

Sénécal K, Vears DF, Bertier G, Knoppers BM, Borry P.
PMID: 29749887
Per Med. 2015 Sep;12(5):439-441. doi: 10.2217/pme.15.28. Epub 2015 Sep 03.

No abstract available.

Cite
Sénécal K, Vears DF, Bertier G, et al. Genome-based newborn screening: a conceptual analysis of the best interests of the child standard. Per Med. 2015;12(5):439-441doi: 10.2217/pme.15.28.
Sénécal, K., Vears, D. F., Bertier, G., Knoppers, B. M., & Borry, P. (2015). Genome-based newborn screening: a conceptual analysis of the best interests of the child standard. Personalized medicine, 12(5), 439-441. https://doi.org/10.2217/pme.15.28
Sénécal, Karine, et al. "Genome-based newborn screening: a conceptual analysis of the best interests of the child standard." Personalized medicine vol. 12,5 (2015): 439-441. doi: https://doi.org/10.2217/pme.15.28
Sénécal K, Vears DF, Bertier G, Knoppers BM, Borry P. Genome-based newborn screening: a conceptual analysis of the best interests of the child standard. Per Med. 2015 Sep;12(5):439-441. doi: 10.2217/pme.15.28. Epub 2015 Sep 03. PMID: 29749887.
Copy Download .nbib Format: NLM
Oral Administration of the Probiotic Strain .

Frontiers in immunology

Secher T, Kassem S, Benamar M, Bernard I, Boury M, Barreau F, Oswald E, Saoudi A.
PMID: 28959254
Front Immunol. 2017 Sep 14;8:1096. doi: 10.3389/fimmu.2017.01096. eCollection 2017.

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) with an increasing incidence in developed countries. Recent reports suggest that modulation of the gut microbiota might be one promising therapy for MS. Here, we...

Cite
Secher T, Kassem S, Benamar M, et al. Oral Administration of the Probiotic Strain . Front Immunol. 2017;8:1096doi: 10.3389/fimmu.2017.01096.
Secher, T., Kassem, S., Benamar, M., Bernard, I., Boury, M., Barreau, F., Oswald, E., & Saoudi, A. (2017). Oral Administration of the Probiotic Strain . Frontiers in immunology, 81096. https://doi.org/10.3389/fimmu.2017.01096
Secher, Thomas, et al. "Oral Administration of the Probiotic Strain ." Frontiers in immunology vol. 8 (2017): 1096. doi: https://doi.org/10.3389/fimmu.2017.01096
Secher T, Kassem S, Benamar M, Bernard I, Boury M, Barreau F, Oswald E, Saoudi A. Oral Administration of the Probiotic Strain . Front Immunol. 2017 Sep 14;8:1096. doi: 10.3389/fimmu.2017.01096. eCollection 2017. PMID: 28959254; PMCID: PMC5603654.
Copy Download .nbib Format: NLM
Genuine participation in participant-centred research initiatives: the rhetoric and the potential reality.

Journal of community genetics

Feeney O, Borry P, Felzmann H, Galvagni L, Haukkala A, Loi M, Nordal S, Rakic V, Riso B, Sterckx S, Vears D.
PMID: 29064073
J Community Genet. 2018 Apr;9(2):133-142. doi: 10.1007/s12687-017-0342-4. Epub 2017 Oct 24.

The introduction of Web 2.0 technology, along with a population increasingly proficient in Information and Communications Technology (ICT), coupled with the rapid advancements in genetic testing methods, has seen an increase in the presence of participant-centred research initiatives. Such...

Cite
Feeney O, Borry P, Felzmann H, et al. Genuine participation in participant-centred research initiatives: the rhetoric and the potential reality. J Community Genet. 2017;9(2):133-142doi: 10.1007/s12687-017-0342-4.
Feeney, O., Borry, P., Felzmann, H., Galvagni, L., Haukkala, A., Loi, M., Nordal, S., Rakic, V., Riso, B., Sterckx, S., & Vears, D. (2018). Genuine participation in participant-centred research initiatives: the rhetoric and the potential reality. Journal of community genetics, 9(2), 133-142. https://doi.org/10.1007/s12687-017-0342-4
Feeney, Oliver, et al. "Genuine participation in participant-centred research initiatives: the rhetoric and the potential reality." Journal of community genetics vol. 9,2 (2018): 133-142. doi: https://doi.org/10.1007/s12687-017-0342-4
Feeney O, Borry P, Felzmann H, Galvagni L, Haukkala A, Loi M, Nordal S, Rakic V, Riso B, Sterckx S, Vears D. Genuine participation in participant-centred research initiatives: the rhetoric and the potential reality. J Community Genet. 2018 Apr;9(2):133-142. doi: 10.1007/s12687-017-0342-4. Epub 2017 Oct 24. PMID: 29064073; PMCID: PMC5849703.
Copy Download .nbib Format: NLM
Internet of Unmanned Aerial Vehicles-A Multilayer Low-Altitude Airspace Model for Distributed UAV Traffic Management.

Sensors (Basel, Switzerland)

Labib NS, Danoy G, Musial J, Brust MR, Bouvry P.
PMID: 31684133
Sensors (Basel). 2019 Nov 03;19(21). doi: 10.3390/s19214779.

The rapid adoption of Internet of Things (IoT) has encouraged the integration of new connected devices such as Unmanned Aerial Vehicles (UAVs) to the ubiquitous network. UAVs promise a pragmatic solution to the limitations of existing terrestrial IoT infrastructure...

Cite
Labib NS, Danoy G, Musial J, et al. Internet of Unmanned Aerial Vehicles-A Multilayer Low-Altitude Airspace Model for Distributed UAV Traffic Management. Sensors (Basel). 2019;19(21)doi: 10.3390/s19214779.
Labib, N. S., Danoy, G., Musial, J., Brust, M. R., & Bouvry, P. (2019). Internet of Unmanned Aerial Vehicles-A Multilayer Low-Altitude Airspace Model for Distributed UAV Traffic Management. Sensors (Basel, Switzerland), 19(21), . https://doi.org/10.3390/s19214779
Labib, Nader S, et al. "Internet of Unmanned Aerial Vehicles-A Multilayer Low-Altitude Airspace Model for Distributed UAV Traffic Management." Sensors (Basel, Switzerland) vol. 19,21 (2019). doi: https://doi.org/10.3390/s19214779
Labib NS, Danoy G, Musial J, Brust MR, Bouvry P. Internet of Unmanned Aerial Vehicles-A Multilayer Low-Altitude Airspace Model for Distributed UAV Traffic Management. Sensors (Basel). 2019 Nov 03;19(21). doi: 10.3390/s19214779. PMID: 31684133; PMCID: PMC6864550.
Copy Download .nbib Format: NLM
Factors that influence data sharing through data sharing platforms: A qualitative study on the views and experiences of cohort holders and platform developers.

PloS one

Devriendt T, Borry P, Shabani M.
PMID: 34214146
PLoS One. 2021 Jul 02;16(7):e0254202. doi: 10.1371/journal.pone.0254202. eCollection 2021.

BACKGROUND: Infrastructures are being developed to enhance and facilitate the sharing of cohort data internationally. However, empirical studies show that many barriers impede sharing data broadly.PURPOSE: Therefore, our aim is to describe the barriers and concerns for the sharing...

Cite
Devriendt T, Borry P, Shabani M. Factors that influence data sharing through data sharing platforms: A qualitative study on the views and experiences of cohort holders and platform developers. PLoS One. 2021;16(7):e0254202doi: 10.1371/journal.pone.0254202.
Devriendt, T., Borry, P., & Shabani, M. (2021). Factors that influence data sharing through data sharing platforms: A qualitative study on the views and experiences of cohort holders and platform developers. PloS one, 16(7), e0254202. https://doi.org/10.1371/journal.pone.0254202
Devriendt, Thijs, et al. "Factors that influence data sharing through data sharing platforms: A qualitative study on the views and experiences of cohort holders and platform developers." PloS one vol. 16,7 (2021): e0254202. doi: https://doi.org/10.1371/journal.pone.0254202
Devriendt T, Borry P, Shabani M. Factors that influence data sharing through data sharing platforms: A qualitative study on the views and experiences of cohort holders and platform developers. PLoS One. 2021 Jul 02;16(7):e0254202. doi: 10.1371/journal.pone.0254202. eCollection 2021. PMID: 34214146; PMCID: PMC8253381.
Copy Download .nbib Format: NLM
Toward better governance of human genomic data.

Nature genetics

O'Doherty KC, Shabani M, Dove ES, Bentzen HB, Borry P, Burgess MM, Chalmers D, De Vries J, Eckstein L, Fullerton SM, Juengst E, Kato K, Kaye J, Knoppers BM, Koenig BA, Manson SM, McGrail KM, McGuire AL, Meslin EM, Nicol D, Prainsack B, Terry SF, Thorogood A, Burke W.
PMID: 33414545
Nat Genet. 2021 Jan;53(1):2-8. doi: 10.1038/s41588-020-00742-6.

No abstract available.

Cite
O'Doherty KC, Shabani M, Dove ES, et al. Toward better governance of human genomic data. Nat Genet. 2021;53(1):2-8doi: 10.1038/s41588-020-00742-6.
O'Doherty, K. C., Shabani, M., Dove, E. S., Bentzen, H. B., Borry, P., Burgess, M. M., Chalmers, D., De Vries, J., Eckstein, L., Fullerton, S. M., Juengst, E., Kato, K., Kaye, J., Knoppers, B. M., Koenig, B. A., Manson, S. M., McGrail, K. M., McGuire, A. L., Meslin, E. M., Nicol, D., Prainsack, B., Terry, S. F., Thorogood, A., & Burke, W. (2021). Toward better governance of human genomic data. Nature genetics, 53(1), 2-8. https://doi.org/10.1038/s41588-020-00742-6
O'Doherty, Kieran C, et al. "Toward better governance of human genomic data." Nature genetics vol. 53,1 (2021): 2-8. doi: https://doi.org/10.1038/s41588-020-00742-6
O'Doherty KC, Shabani M, Dove ES, Bentzen HB, Borry P, Burgess MM, Chalmers D, De Vries J, Eckstein L, Fullerton SM, Juengst E, Kato K, Kaye J, Knoppers BM, Koenig BA, Manson SM, McGrail KM, McGuire AL, Meslin EM, Nicol D, Prainsack B, Terry SF, Thorogood A, Burke W. Toward better governance of human genomic data. Nat Genet. 2021 Jan;53(1):2-8. doi: 10.1038/s41588-020-00742-6. PMID: 33414545; PMCID: PMC8450011.
Copy Download .nbib Format: NLM
Electrophysiological Evaluation of Pacific Oyster (.

Marine drugs

Boullot F, Fabioux C, Hégaret H, Boudry P, Soudant P, Benoit E.
PMID: 34209313
Mar Drugs. 2021 Jun 30;19(7). doi: 10.3390/md19070380.

Pacific oysters (

Cite
Boullot F, Fabioux C, Hégaret H, et al. Electrophysiological Evaluation of Pacific Oyster (. Mar Drugs. 2021;19(7)doi: 10.3390/md19070380.
Boullot, F., Fabioux, C., Hégaret, H., Boudry, P., Soudant, P., & Benoit, E. (2021). Electrophysiological Evaluation of Pacific Oyster (. Marine drugs, 19(7), . https://doi.org/10.3390/md19070380
Boullot, Floriane, et al. "Electrophysiological Evaluation of Pacific Oyster (." Marine drugs vol. 19,7 (2021). doi: https://doi.org/10.3390/md19070380
Boullot F, Fabioux C, Hégaret H, Boudry P, Soudant P, Benoit E. Electrophysiological Evaluation of Pacific Oyster (. Mar Drugs. 2021 Jun 30;19(7). doi: 10.3390/md19070380. PMID: 34209313; PMCID: PMC8307532.
Copy Download .nbib Format: NLM
Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells.

Frontiers in bioengineering and biotechnology

Séhédic D, Roncali L, Djoudi A, Buchtova N, Avril S, Chérel M, Boury F, Lacoeuille F, Hindré F, Garcion E.
PMID: 33718332
Front Bioeng Biotechnol. 2021 Feb 25;8:602998. doi: 10.3389/fbioe.2020.602998. eCollection 2020.

Inhibition of the PI3K/Akt/mTOR signaling pathway represents a potential issue for the treatment of cancer, including glioblastoma. As such, rapamycin that inhibits the mechanistic target of rapamycin (mTOR), the downstream effector of this signaling pathway, is of great interest....

Cite
Séhédic D, Roncali L, Djoudi A, et al. Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells. Front Bioeng Biotechnol. 2021;8:602998doi: 10.3389/fbioe.2020.602998.
Séhédic, D., Roncali, L., Djoudi, A., Buchtova, N., Avril, S., Chérel, M., Boury, F., Lacoeuille, F., Hindré, F., & Garcion, E. (2020). Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells. Frontiers in bioengineering and biotechnology, 8602998. https://doi.org/10.3389/fbioe.2020.602998
Séhédic, Delphine, et al. "Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells." Frontiers in bioengineering and biotechnology vol. 8 (2020): 602998. doi: https://doi.org/10.3389/fbioe.2020.602998
Séhédic D, Roncali L, Djoudi A, Buchtova N, Avril S, Chérel M, Boury F, Lacoeuille F, Hindré F, Garcion E. Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells. Front Bioeng Biotechnol. 2021 Feb 25;8:602998. doi: 10.3389/fbioe.2020.602998. eCollection 2020. PMID: 33718332; PMCID: PMC7947795.
Copy Download .nbib Format: NLM
Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation.

mBio

Maikova A, Boudry P, Shiriaeva A, Vasileva A, Boutserin A, Medvedeva S, Semenova E, Severinov K, Soutourina O.
PMID: 34425703
mBio. 2021 Aug 31;12(4):e0213621. doi: 10.1128/mBio.02136-21. Epub 2021 Aug 24.

CRISPR (

Cite
Maikova A, Boudry P, Shiriaeva A, et al. Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation. mBio. 2021;12(4):e0213621doi: 10.1128/mBio.02136-21.
Maikova, A., Boudry, P., Shiriaeva, A., Vasileva, A., Boutserin, A., Medvedeva, S., Semenova, E., Severinov, K., & Soutourina, O. (2021). Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation. mBio, 12(4), e0213621. https://doi.org/10.1128/mBio.02136-21
Maikova, Anna, et al. "Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation." mBio vol. 12,4 (2021): e0213621. doi: https://doi.org/10.1128/mBio.02136-21
Maikova A, Boudry P, Shiriaeva A, Vasileva A, Boutserin A, Medvedeva S, Semenova E, Severinov K, Soutourina O. Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation. mBio. 2021 Aug 31;12(4):e0213621. doi: 10.1128/mBio.02136-21. Epub 2021 Aug 24. PMID: 34425703; PMCID: PMC8406132.
Copy Download .nbib Format: NLM
Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation.

mBio

Maikova A, Boudry P, Shiriaeva A, Vasileva A, Boutserin A, Medvedeva S, Semenova E, Severinov K, Soutourina O.
PMID: 34425703
mBio. 2021 Aug 31;12(4):e0213621. doi: 10.1128/mBio.02136-21. Epub 2021 Aug 24.

CRISPR (

Cite
Maikova A, Boudry P, Shiriaeva A, et al. Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation. mBio. 2021;12(4):e0213621doi: 10.1128/mBio.02136-21.
Maikova, A., Boudry, P., Shiriaeva, A., Vasileva, A., Boutserin, A., Medvedeva, S., Semenova, E., Severinov, K., & Soutourina, O. (2021). Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation. mBio, 12(4), e0213621. https://doi.org/10.1128/mBio.02136-21
Maikova, Anna, et al. "Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation." mBio vol. 12,4 (2021): e0213621. doi: https://doi.org/10.1128/mBio.02136-21
Maikova A, Boudry P, Shiriaeva A, Vasileva A, Boutserin A, Medvedeva S, Semenova E, Severinov K, Soutourina O. Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation. mBio. 2021 Aug 31;12(4):e0213621. doi: 10.1128/mBio.02136-21. Epub 2021 Aug 24. PMID: 34425703; PMCID: PMC8406132.
Copy Download .nbib Format: NLM
Showing 217 to 228 of 228 entries